Alembic Pharmaceuticals Limited
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of major depressive disorder, generalized anxiety disorder, as well as diabetic peripheral neuropathic pain.
Dosage form: capsules, solid modified-release
Active substance Dosage duloxetine 30 mg ATC: N06AX21
-
The drug is used for the treatment of major depressive disorder, generalized anxiety disorder, as well as diabetic peripheral neuropathic pain.
Dosage form: capsules, solid modified-release
Active substance Dosage duloxetine 60 mg ATC: N06AX21
-
These medications are prescribed to adults for the treatment of essential hypertension (high blood pressure) if it cannot be controlled with irbesartan or hydrochlorothiazide alone.
Dosage form: tablets
Active substance Dosage irbesartan 150 mg hydrochlorothiazide 12.5 mg ATC: C09DA04
-
These medications are prescribed to adults for the treatment of essential hypertension (high blood pressure) if it cannot be controlled using a single component (irbesartan or hydrochlorothiazide) alone.
Dosage form: tablets
Active substance Dosage irbesartan 300 mg hydrochlorothiazide 12.5 mg ATC: C09DA04
-
These medications are prescribed for the treatment of essential arterial hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
-
These medications are prescribed for the treatment of essential arterial hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults who do not achieve adequate control with a single component (olmesartan medoxomil) alone.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
-
The drug is used for the treatment of schizophrenia in adults, as well as for the treatment and prevention of manic episodes in bipolar I disorder.
Dosage form: tablets
Active substance Dosage aripiprazole 10 mg ATC: N05AX12
-
The drug is used for the treatment of schizophrenia in adults, as well as for the treatment of moderate to severe manic episodes in bipolar I disorder and for the prevention of new manic episodes.
Dosage form: tablets
Active substance Dosage aripiprazole 15 mg ATC: N05AX12
-
The drug is used for the treatment of schizophrenia in adults, as well as for the treatment and prevention of manic episodes in bipolar I disorder.
Dosage form: tablets
Active substance Dosage aripiprazole 30 mg ATC: N05AX12
-
The drug is used for the treatment of schizophrenia in adults, as well as for the treatment and prevention of manic episodes in bipolar I disorder.
Dosage form: tablets
Active substance Dosage aripiprazole 5 mg ATC: N05AX12
-
The drug is prescribed to adults for the treatment of essential hypertension (high blood pressure) if it has not been successfully controlled using only one component (amlodipine or valsartan) alone.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg ATC: C09DB01
-
The drug is prescribed for adults to treat essential hypertension (high blood pressure) if it cannot be controlled by using only one component (amlodipine or valsartan) alone.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 5 mg valsartan 160 mg ATC: C09DB01
-
The drug is used to treat signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Dosage form: tablets
Active substance Dosage pramipexole 0.175 mg ATC: N04BC05
-
The drug is used to treat signs and symptoms of Parkinson's disease in adults (either as monotherapy or in combination with levodopa), as well as for the symptomatic treatment of moderate to severe restless legs syndrome.
Dosage form: tablets
Active substance Dosage pramipexole 0.7 mg ATC: N04BC05